Insider filing · GLUE
Edmund Dunn
Principal Accounting Officer
profile →
Monte Rosa Therapeutics, Inc.
GLUE · Healthcare · 17 filings in 24 months
ticker →
Edmund Dunn sold $455K of Monte Rosa Therapeutics (GLUE)
Executed Feb 27, disclosed Mar 2, 3 days later.
Value, as filed
$455K
25,164 sh × $18.10
Executed
Feb 27
the trade date, as filed
Disclosed
Mar 2
3 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
EDEdmund Dunn (Principal Accounting Officer) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Monte Rosa Therapeutics, Inc. (GLUE). The largest single filing was $455K of GLUE (25,164 sh × $18.10, as filed), executed Feb 27.
The name
GLUEHealthcare · Monte Rosa Therapeutics, Inc., a clinical-stage biotechnology company, engages in the development of novel small molecule precision medicin…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→